Application of RNA-Seq transcriptome analysis: CD151 is an Invasion/Migration target in all stages of epithelial ovarian cancer

<p>Abstract</p> <p>Background</p> <p>RNA-Seq allows a theoretically unbiased analysis of both genome-wide transcription levels and mutation status of a tumor. Using this technique we sought to identify novel candidate therapeutic targets expressed in epithelial ovarian...

Full description

Bibliographic Details
Main Authors: Mosig Rebecca A, Lin Li, Senturk Emir, Shah Hardik, Huang Fei, Schlosshauer Peter, Cohen Samantha, Fruscio Robert, Marchini Sergio, D'Incalci Maurizio, Sachidanandam Ravi, Dottino Peter, Martignetti John A
Format: Article
Language:English
Published: BMC 2012-01-01
Series:Journal of Ovarian Research
Subjects:
Online Access:http://www.ovarianresearch.com/content/5/1/4
_version_ 1828082682835238912
author Mosig Rebecca A
Lin Li
Senturk Emir
Shah Hardik
Huang Fei
Schlosshauer Peter
Cohen Samantha
Fruscio Robert
Marchini Sergio
D'Incalci Maurizio
Sachidanandam Ravi
Dottino Peter
Martignetti John A
author_facet Mosig Rebecca A
Lin Li
Senturk Emir
Shah Hardik
Huang Fei
Schlosshauer Peter
Cohen Samantha
Fruscio Robert
Marchini Sergio
D'Incalci Maurizio
Sachidanandam Ravi
Dottino Peter
Martignetti John A
author_sort Mosig Rebecca A
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>RNA-Seq allows a theoretically unbiased analysis of both genome-wide transcription levels and mutation status of a tumor. Using this technique we sought to identify novel candidate therapeutic targets expressed in epithelial ovarian cancer (EOC).</p> <p>Methods</p> <p>Specifically, we sought candidate invasion/migration targets based on expression levels across all tumors, novelty of expression in EOC, and known function. RNA-Seq analysis revealed the high expression of CD151, a transmembrane protein, across all stages of EOC. Expression was confirmed at both the mRNA and protein levels using RT-PCR and immunohistochemical staining, respectively.</p> <p>Results</p> <p>In both EOC tumors and normal ovarian surface epithelial cells we demonstrated CD151 to be localized to the membrane and cell-cell junctions in patient-derived and established EOC cell lines. We next evaluated its role in EOC dissemination using two ovarian cancer-derived cell lines with differential levels of CD151 expression. Targeted antibody-mediated and siRNA inhibition or loss of CD151 in SKOV3 and OVCAR5 cell lines effectively inhibited their migration and invasion.</p> <p>Conclusion</p> <p>Taken together, these findings provide the first proof-of-principle demonstration for a next generation sequencing approach to identifying candidate therapeutic targets and reveal CD151 to play a role in EOC dissemination.</p>
first_indexed 2024-04-11T03:55:51Z
format Article
id doaj.art-ff693e0a1aab497ca4913c51d0812b83
institution Directory Open Access Journal
issn 1757-2215
language English
last_indexed 2024-04-11T03:55:51Z
publishDate 2012-01-01
publisher BMC
record_format Article
series Journal of Ovarian Research
spelling doaj.art-ff693e0a1aab497ca4913c51d0812b832023-01-02T00:37:16ZengBMCJournal of Ovarian Research1757-22152012-01-0151410.1186/1757-2215-5-4Application of RNA-Seq transcriptome analysis: CD151 is an Invasion/Migration target in all stages of epithelial ovarian cancerMosig Rebecca ALin LiSenturk EmirShah HardikHuang FeiSchlosshauer PeterCohen SamanthaFruscio RobertMarchini SergioD'Incalci MaurizioSachidanandam RaviDottino PeterMartignetti John A<p>Abstract</p> <p>Background</p> <p>RNA-Seq allows a theoretically unbiased analysis of both genome-wide transcription levels and mutation status of a tumor. Using this technique we sought to identify novel candidate therapeutic targets expressed in epithelial ovarian cancer (EOC).</p> <p>Methods</p> <p>Specifically, we sought candidate invasion/migration targets based on expression levels across all tumors, novelty of expression in EOC, and known function. RNA-Seq analysis revealed the high expression of CD151, a transmembrane protein, across all stages of EOC. Expression was confirmed at both the mRNA and protein levels using RT-PCR and immunohistochemical staining, respectively.</p> <p>Results</p> <p>In both EOC tumors and normal ovarian surface epithelial cells we demonstrated CD151 to be localized to the membrane and cell-cell junctions in patient-derived and established EOC cell lines. We next evaluated its role in EOC dissemination using two ovarian cancer-derived cell lines with differential levels of CD151 expression. Targeted antibody-mediated and siRNA inhibition or loss of CD151 in SKOV3 and OVCAR5 cell lines effectively inhibited their migration and invasion.</p> <p>Conclusion</p> <p>Taken together, these findings provide the first proof-of-principle demonstration for a next generation sequencing approach to identifying candidate therapeutic targets and reveal CD151 to play a role in EOC dissemination.</p>http://www.ovarianresearch.com/content/5/1/4CD151Epithelial Ovarian CancerInvasionMigrationMetastasisRNA-Seq
spellingShingle Mosig Rebecca A
Lin Li
Senturk Emir
Shah Hardik
Huang Fei
Schlosshauer Peter
Cohen Samantha
Fruscio Robert
Marchini Sergio
D'Incalci Maurizio
Sachidanandam Ravi
Dottino Peter
Martignetti John A
Application of RNA-Seq transcriptome analysis: CD151 is an Invasion/Migration target in all stages of epithelial ovarian cancer
Journal of Ovarian Research
CD151
Epithelial Ovarian Cancer
Invasion
Migration
Metastasis
RNA-Seq
title Application of RNA-Seq transcriptome analysis: CD151 is an Invasion/Migration target in all stages of epithelial ovarian cancer
title_full Application of RNA-Seq transcriptome analysis: CD151 is an Invasion/Migration target in all stages of epithelial ovarian cancer
title_fullStr Application of RNA-Seq transcriptome analysis: CD151 is an Invasion/Migration target in all stages of epithelial ovarian cancer
title_full_unstemmed Application of RNA-Seq transcriptome analysis: CD151 is an Invasion/Migration target in all stages of epithelial ovarian cancer
title_short Application of RNA-Seq transcriptome analysis: CD151 is an Invasion/Migration target in all stages of epithelial ovarian cancer
title_sort application of rna seq transcriptome analysis cd151 is an invasion migration target in all stages of epithelial ovarian cancer
topic CD151
Epithelial Ovarian Cancer
Invasion
Migration
Metastasis
RNA-Seq
url http://www.ovarianresearch.com/content/5/1/4
work_keys_str_mv AT mosigrebeccaa applicationofrnaseqtranscriptomeanalysiscd151isaninvasionmigrationtargetinallstagesofepithelialovariancancer
AT linli applicationofrnaseqtranscriptomeanalysiscd151isaninvasionmigrationtargetinallstagesofepithelialovariancancer
AT senturkemir applicationofrnaseqtranscriptomeanalysiscd151isaninvasionmigrationtargetinallstagesofepithelialovariancancer
AT shahhardik applicationofrnaseqtranscriptomeanalysiscd151isaninvasionmigrationtargetinallstagesofepithelialovariancancer
AT huangfei applicationofrnaseqtranscriptomeanalysiscd151isaninvasionmigrationtargetinallstagesofepithelialovariancancer
AT schlosshauerpeter applicationofrnaseqtranscriptomeanalysiscd151isaninvasionmigrationtargetinallstagesofepithelialovariancancer
AT cohensamantha applicationofrnaseqtranscriptomeanalysiscd151isaninvasionmigrationtargetinallstagesofepithelialovariancancer
AT frusciorobert applicationofrnaseqtranscriptomeanalysiscd151isaninvasionmigrationtargetinallstagesofepithelialovariancancer
AT marchinisergio applicationofrnaseqtranscriptomeanalysiscd151isaninvasionmigrationtargetinallstagesofepithelialovariancancer
AT dincalcimaurizio applicationofrnaseqtranscriptomeanalysiscd151isaninvasionmigrationtargetinallstagesofepithelialovariancancer
AT sachidanandamravi applicationofrnaseqtranscriptomeanalysiscd151isaninvasionmigrationtargetinallstagesofepithelialovariancancer
AT dottinopeter applicationofrnaseqtranscriptomeanalysiscd151isaninvasionmigrationtargetinallstagesofepithelialovariancancer
AT martignettijohna applicationofrnaseqtranscriptomeanalysiscd151isaninvasionmigrationtargetinallstagesofepithelialovariancancer